Philip A. Thompson - Publications, H-index & Citations

Back

Philip A. Thompson

Peter MacCallum Cancer Centre and Royal Melbourne Hospital

50H-index

363Paper Count

1.1WCitation Count

Published Papers 74

Publication Date

Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia

Blood Advances

IF7.1

2026-07-28

OAAI

Sean McKeague; Thomas E. Lew; Anna Lowe; Leishong Lau; Philip A. Thompson; Ashley Whitechurch; Dennis Carney; Max Wolf; Gemma Reynolds; Piers Blombery; John F. Seymour; Andrew W. Roberts; Mary Ann Anderson

Save

NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapy

Blood Advances

IF7.1

2026-03-27

OAAI

Alexandre Bazinet; Alessandra Ferrajoli; Nitin Jain; Jan Burger; Musa Yilmaz; Mahesh Swaminathan; Hagop Kantarjian; Michael Keating; Philip A. Thompson; William G. Wierda

Save

Venetoclax Retreatment in Chronic Lymphocytic Leukemia is biologically rational and clinically effective

Blood Advances

IF7.1

2026-03-19

OAAI

Mathias Castonguay; Mary Ann Anderson; Philip Thompson; John F. Seymour

Save

Impact of Prior Bendamustine Exposure on Bispecific Antibody Outcomes in Relapsed/Refractory Follicular Lymphoma

Blood Advances

IF7.1

2026-01-09

OAAI

Gloria Iacoboni; Emil Ramsø Kyvsgaard; Victor Navarro Garces; David A. Russler-Germain; Katharine Lewis; Alejandro Martín García-Sancho; Itziar Carro; Philip A. Thompson; Dylan Therwhanger; David Quintela; Matthew Ku; Pilar Gómez; Evelyn Valencia; Gala Vega; Ana Jiménez-Ubieto; Mariana Bastos-Oreiro; Angel Serna; Simon Husby; Beatriz De La Cruz; Jing Luan

Save

Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma

Blood Advances

IF7.1

2025-12-15

OAAI

Sasanka M. Handunnetti; Amit Khot; Piers Blombery; Kate Burbury; Philip A. Thompson; David Ritchie; Rodney J. Hicks; Glenda Burke; Rachel Koldej; Mathias Bressel; Juliana Di Iulio; David A. Westerman; Stephen Lade; Andrew W. Roberts; John F. Seymour; Constantine S. Tam; Mary Ann Anderson

Save

Balancing gains and pains: infections in the bispecific era

LEUKEMIA & LYMPHOMA

IF2.2

2025-11-01

PREAI

Ibrahim, Nalian H.; Thompson, Philip A.; Teh, Benjamin W.

Save

Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression

Blood Cancer Journal

IF11.6

2025-10-27

OAAI

Shady I. Tantawy; Burcu Aslan; Ganiraju Manyam; LaKesla R. Iles; Natalia Timofeeva; Neetu Singh; Nitin Jain; Alessandra Ferrajoli; Philip A. Thompson; Keyur P. Patel; Sai Prasad Desikan; William G. Wierda; Varsha Gandhi

Save

Advances in the Understanding of Richter Transformation

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

IF2.7

2025-10-01

PREAI

Thompson, Philip A.; Parry, Erin M.

Save

Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukemia

Blood

IF23.1

2025-04-12

PREAI

Brian T. Grainger; Philip A. Thompson; Chan Y. Cheah

Save

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

BLOOD CANCER JOURNAL

IF11.6

2025-02-20

OAAI

Kittai, Adam S.; Huang, Ying; Miller, Sarah; Allan, John N.; Bhat, Seema A.; Bond, David A.; Brander, Danielle M.; Byrd, John C.; Chavez, Julio C.; Chong, Elise; Davids, Matthew S.; Danilov, Alexey V.; Ding, Wei; Dowling, Mark R.; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J.; Ho, Carrie; Hwang, Steven R.; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A.; Parry, Erin; Rabe, Kari G.; Raess, Philipp W.; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A.; Saha, Aditi; Schade, Jake; Scott, Hamish W.; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M.; Thompson, Meghan C.; Thompson, Philip A.; Wang, Yucai; Yano, Max; Woyach, Jennifer A.

Save

Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study

LANCET HAEMATOLOGY

IF17.7

2024-09-01

PREAI

Wierda, William G.; Shah, Nirav N.; Cheah, Chan Y.; Lewis, David; Hoffmann, Marc S.; Coombs, Catherine C.; Lamanna, Nicole; Ma, Shuo; Jagadeesh, Deepa; Munir, Talha; Wang, Yucai; Eyre, Toby A.; Rhodes, Joanna M.; McKinney, Matthew; Lech-Maranda, Ewa; Tam, Constantine S.; Jurczak, Wojciech; Izutsu, Koji; Alencar, Alvaro J.; Patel, Manish R.; Seymour, John F.; Woyach, Jennifer A.; Thompson, Philip A.; Abada, Paolo B.; Ho, Caleb; McNeely, Samuel C.; Marella, Narasimha; Nguyen, Bastien; Wang, Chunxiao; Ruppert, Amy S.; Nair, Binoj; Liu, Hui; Tsai, Donald E.; Roeker, Lindsey E.; Ghia, Paolo

Save

Ending endless follow-up for low-risk CLL?

BLOOD ADVANCES

IF7.1

2024-08-27

OAAI

Thompson, Philip A.

Save

A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia

BLOOD ADVANCES

IF7.1

2024-05-17

OAAI

Hampel, Paul J.; Swaminathan, Mahesh; Rogers, Kerry A.; Parry, Erin M.; Burger, Jan A.; Davids, Matthew S.; Ding, Wei; Ferrajoli, Alessandra; Hyak, Jonathan M.; Jain, Nitin; Kenderian, Saad S.; Wang, Yucai; Wierda, William G.; Woyach, Jennifer A.; Parikh, Sameer A.; Thompson, Philip A.

Save

BTK inhibitors in CLL: second-generation drugs and beyond

BLOOD ADVANCES

IF7.1

2024-05-14

OAAI

Tam, Constantine; Thompson, Philip A.

Save

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon

BLOOD ADVANCES

IF7.1

2024-03-15

OAAI

Lew, Thomas E.; Bennett, Rory; Lin, Victor S.; Whitechurch, Ashley; Handunnetti, Sasanka M.; Marlton, Paula; Shen, Yandong; Mulligan, Stephen P.; Casan, Joshua; Blombery, Piers; Tam, Constantine S.; Roberts, Andrew W.; Seymour, John F.; Thompson, Philip A.; Anderson, Mary A.

Save

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies

BLOOD ADVANCES

IF7.1

2023-09-27

OAAI

Chien, Kelly S.; Peterson, Christine B.; Young, Elliana; Chihara, Dai; Manasanch, Elizabet E.; Ramdial, Jeremy L.; Thompson, Philip A.

Save

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

BLOOD ADVANCES

IF7.1

2023-08-23

OAAI

Ujjani, Chaitra; Gooley, Ted A.; Spurgeon, Stephen E.; Stephens, Deborah M.; Lai, Catherine; Broome, Catherine M.; O'Brien, Susan; Zhu, Haiying; Laing, Kerry J.; Winter, Allison M.; Pongas, Georgios; Greninger, Alexander L.; Koelle, David M.; Siddiqi, Tanya; Davids, Matthew S.; Rogers, Kerry A.; V. Danilov, Alexey; Sperling, Amy; Tu, Brian; Sorensen, Tyler; Launchbury, Kelsey; Burrow, Carlissa J.; Quezada, Genesis; Hill, Joshua A.; Shadman, Mazyar; Thompson, Philip A.

Save

Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity

BLOOD ADVANCES

IF7.1

2023-07-03

OAAI

Bazinet, Alexandre; Kadia, Tapan; Short, Nicholas J.; Borthakur, Gautam; Wang, Sa A.; Wang, Wei; Loghavi, Sanam; Jorgensen, Jeffrey; Patel, Keyur; DiNardo, Courtney; Daver, Naval; Alvarado, Yesid; Haddad, Fadi G.; Pierce, Sherry; Gonzalez, Graciela Nogueras; Maiti, Abhishek; Sasaki, Koji; Yilmaz, Musa; Thompson, Philip; Wierda, William; Garcia-Manero, Guillermo; Andreeff, Michael; Jabbour, Elias; Konopleva, Marina; Huang, Xuelin; Kantarjian, Hagop; Ravandi, Farhad

Save

A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL

BLOOD ADVANCES

IF7.1

2023-05-10

OAAI

Jain, Nitin; Senapati, Jayastu; Thakral, Beenu; Ferrajoli, Alessandra; Thompson, Philip; Burger, Jan; Basu, Sreyashi; Kadia, Tapan; Daver, Naval; Borthakur, Gautam; Konopleva, Marina; Pemmaraju, Naveen; Parry, Erin; Wu, Catherine J.; Khoury, Joseph; Bueso-Ramos, Carlos; Garg, Naveen; Wang, Xuemei; Lopez, Wanda; Ayala, Ana; O'Brien, Susan; Kantarjian, Hagop; Keating, Michael; Allison, James; Sharma, Padmane; Wierda, William

Save

Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD

LEUKEMIA

IF13.4

2023-05-03

OAAI

Thompson, Philip A. A.; Keating, Michael J. J.; Ferrajoli, Alessandra; Jain, Nitin; Peterson, Christine B. B.; Garg, Naveen; Wang, Sa A. A.; Jorgensen, Jeffrey L. L.; Kadia, Tapan M. M.; Bose, Prithviraj; Pemmaraju, Naveen; Short, Nicholas J. J.; Wierda, William G. G.

Save

Research Directions